Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Samira purchased 20,000 shares & 425,000 options expire
View:
Post by MrMugsy on Mar 30, 2022 5:24pm

Samira purchased 20,000 shares & 425,000 options expire

Filed 2022-03-30 16:57
 
Tx date 2022-03-25
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options
$-2,537,500
-290,000 vol
$8.75 each
2,179,548  
Filed 2022-03-30 16:52
 
Tx date 2022-03-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-1,181,250
-135,000 vol
$8.75 each
424,758  
Filed 2022-03-30 16:06
 
Tx date 2022-03-30
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$103,600
+20,000 vol
$5.18 each
117,429
Comment by wofats on Mar 30, 2022 6:07pm
There was a lot of PSUs and RSUs given out on the 29 also. The performance ones will be very interesting .The sales team is being incentified perhaps.
Comment by MrMugsy on Mar 31, 2022 9:07am
Yes - agreed ! -------------------------- a few additional expriations. Filed 2022-03-30 17:01   Tx date 2022-03-25 $GUD Knight Therapeutics Inc. Lande, Robert Nathaniel 4 - Director of Issuer Direct Ownership Options 52 - Expiration of options $-175,000 -20,000 vol  ...more  
Comment by Chianchin on Mar 31, 2022 12:13pm
For the past 8 Years GUD has given options to MNGT and others. Well!!!! not a single option has been excercised to the best of my knowledge. Why? Ha..the stock option price never met profit expectation/target.   
Comment by MrMugsy on Mar 31, 2022 12:40pm
You might be right Chi-Chi but what's your point?  Where do you want to take that idea? Keep in mind that while the price is lower than the option price, those people have been buying at market.  They're still accumulating shares and getting a better price. I know you don't like that - but - that's the way it is. I know you bought your shares at $10 Chi-Chi (Cluey) ... ...more  
Comment by gossamer9 on Mar 30, 2022 11:31pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities